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Abstract
Introduction: Magnetic resonance imaging (MRI) was used to study the hand and wrist in very early rheumatoid
arthritis (RA), and the results were compared with early and established disease.
Methods: Fifty-seven patients fulfilling the new American College of Rheumatology criteria for RA, 26 with very
early RA (VERA), 18 with early RA (ERA), and 13 with established RA (ESTRA), (disease duration < 3 months, < 12
months, and > 12 months, respectively) were enrolled in the study. MRI of the dominant hand and wrist was
performed by using fat-suppressed T2-weighted and plain and contrast-enhanced T1-weighted sequences.
Evaluation of bone marrow edema, synovitis, and bone erosions was performed with the OMERACT RA MRI scoring
system.
Results: Edema, erosions, and synovitis were present in VERA, and the prevalence was 100%, 96.15%, and 92.3%,
respectively. Significant differences in edema and erosions were found between VERA and ESTRA (P < 0.05). No
significant difference was found in synovitis.
Conclusions: Edema, erosions, and synovitis are findings of very early RA. MRI, by detecting these lesions, may play
an important role in the management of these patients.
Introduction
Rheumatoid arthritis (RA) is a chronic systemic inflam-
matory disease characterized by prominent joint mani-
festations. Inflammation of the synovial membrane leads
to the formation of a highly cellular inflammatory tissue,
the pannus, which, by eroding cartilage and bone, leads
to joint destruction and ankylosis [1]. Articular involve-
ment of the hand and wrist has been considered a very
frequent presenting finding [1]. The presence of mar-
ginal erosions, seen on conventional radiographs of the
hand and wrist, has been viewed as a specific and rela-
tively sensitive diagnostic finding [2]. Conventional
radiographs cannot assess synovitis, bone edema, and
early marginal erosions [3-8]. Bone edema, erosions, and
synovitis have been detected by magnetic resonance
imaging (MRI) in patients with disease duration of < 1
year [3,4,8-15]. Bone edema and erosions are considered
red flags for progression of bone damage in the future,
and thus, modern concepts in RA imply that treatment
with conventional disease-modifying antirheumatic
drugs (DMARDs) and particularly biologic DMARDs,
should ideally be started before erosive disease is
detected [16-20]. Nevertheless, no studies have evaluated
with MRI the hand and wrist of patients with disease
duration of less than 3 months.
The purpose of this study was to assess with MRI in
very early RA (VERA) the prevalence and severity of
hand and wrist involvement and to compare the invol-
vement with early RA (ERA) and established RA
(ESTRA).
Materials and methods
Patients
Fifty-seven consecutive unselected patients with RA,
according to the new criteria for RA [2] and without
prior use of DMARDs, were enrolled in the study. The
37 women and 20 men were aged 17 to 83 years (mean,
57.52 ± 15.82 years). According to disease duration, the
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patients with very early disease (< 3 months) (VERA);
Group 2, 18 patients with early disease (< 12 months)
(ERA); and Group 3, 13 patients with established dis-
ease (> 12 months) (ESTRA). Each patient underwent
a complete physical examination by the same rheuma-
tologist (PVV). Clinical disease variables included the
duration of morning stiffness (minutes), grip strength
(mm Hg), total joint count with tenderness or swelling,
number of swollen joints, number of tender joints, and
pain score (on visual analogue scale (VAS; centi-
meters)). Laboratory disease variables included C-reac-
tive protein (CRP), erythrocyte sedimentation rate
(ESR), rheumatoid factor (RF), and anticitrullinated
cyclic peptide (CCP). For assessing disease activity, the
disease activity score for 28 joint indices (DAS-28) was
calculated [21]. An MRI of the dominant hand and
wrist was performed in the same MRI unit (1.5 Tesla;
Gyroscan ACS NT; Philips Medical Systems, Best, The
Netherlands) by using a surface coil with a 20-cm field
of view. The patient lay prone with the arm to be stu-
died extended overhead toward the midline. The ima-
ging protocol consisted of axial and coronal STIR
images with 2,500, 60, 160 (repetition time, ms/echo
time, ms/inversion time, m s )3 - m ms l i c et h i c k n e s s ,
0.3-mm intersection gap, 256 × 256 imaging matrix,
coronal spin-echo T1-weighted images with 500, 16
(repetition time, ms; echo time, ms) 3-mm slice thick-
ness, 0.3-mm intersection gap, 256 × 256 imaging
matrix; and coronal spin-echo fat-suppressed, T1-
weighted images with 500, 16 (repetition time, ms/
echo time, ms) 3-mm slice thickness, 0.3-mm intersec-
tion gap, 256 × 256 imaging matrix before and coronal
and axial images immediately after intravenous admin-
istration of 0.1 mmol/kg Gd-DTPA. Intravenous con-
t r a s ti n j e c t i o nw a sp e r f o r m e dt h r o u g hav e i ni nt h e
contralateral arm. Diffusion of contrast material into
joint effusions was avoided in coronal scans performed
immediately after contrast administration (duration of
postcontrast coronal sequence, 2.5 minutes). Hand and
wrist involvement was evaluated by using the OMER-
ACT RA MRI scoring system to assess bone edema
(Figure 1), erosions (Figure 2); and synovitis (Figure 3)
[22,23]. Evaluations of all MRI examinations were per-
formed independently by two musculoskeletal radiolo-
gists (PEK, AKZ) blinded to the patients’ identity,
clinical status, and disease duration. STIR images were
evaluated for bone edema, and plain and contrast-
enhanced fat-suppressed T1-weighted coronal and
axial images were evaluated for erosions and synovitis.
Because the thinnest slice that could be obtained was 3
mm, attention was paid to avoid considering as bone
erosions areas of irregular bone contours or ligamen-
tous attachments [24]. The study was approved by the
Institutional Review Board, and written informed con-
sent was obtained from all subjects.
Statistical analysis
Statistical analysis was performed with SPSS base 15 for
Windows. Interobserver variability was evaluated by
using the Pearson correlation coefficient. Analysis of
variance (ANOVA), followed by the least significant dif-
ference test, was used to study differences between
groups. A P value less than 0.05 was considered statisti-
cally significant.
Results
The clinical features of the patients are shown in
Table 1. The interobserver variability was R = 0.95 for
edema, 0.95 for erosions, and 0.97 for synovitis. Bone
edema, erosions, and synovitis were present in all groups
of RA (Table 2). Analysis of variance demonstrated that
the three groups were significantly different for bone
edema and erosions. The least significant difference test
revealed significant difference in bone edema and ero-
sions between VERA and ESTRA; P <0 . 0 5( T a b l e3 ) .
Comparison between VERA and ERA in terms of local
distribution of lesions revealed significant difference in
erosions of the MCP (Table 4).
Figure 1 Coronal short time inversion recovery scan shows
edema in trapezium and the first metacarpal bone. Repetition
time/2,500 ms, echo time/60 ms, inversion time/160 ms.
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imaging findings and the clinical (duration of morning
stiffness (min), grip strength (mm Hg), total joint
count with tenderness or swelling, number of swollen
joints, number of tender joints and pain score on VAS
(cm)) and laboratory findings (CRP, ESR, RF, anti-
CCP, and DAS-28).
Discussion
In this study, the OMERACT RA MRI scoring system
was applied to look for differences in bone edema, ero-
sions, and synovitis between VERA, ERA, and ESTRA,
and the major findings were (a) the presence of bone
edema, erosions, and synovitis at the very early stages of
RA; and (b) a significant difference in bone edema and
erosions between VERA and ESTRA.
MRI is being used largely in the assessment of hand
and wrist involvement of patients with RA [3,5-7,13-16].
Most of the studies have been performed in patients
with late early and established disease. Only one study
evaluated patients with disease duration less than 4
months [4]. This study demonstrated an incidence of
bone erosions of 45%, but half of the patients were
receiving DMARDs. The present study demonstrated a
very high incidence of bone erosions (96%) in a treat-
ment-naïve population evaluated at a very early stage of
RA. The lack of treatment and the evaluation of the
MCP joints, which are characteristically affected in early
RA [14], may probably explain the difference in inci-
dence of bone erosions. Previous studies, by demonstrat-
ing very early the presence of anti-CCP antibodies and
RF, have suggested that the disease process in RA starts
long before the onset of symptoms [25]. This study, by
demonstrating bone erosions in VERA, reinforces this
hypothesis. Another interesting finding of this study was
t h ep r e s e n c eo fb o n ee d e m ai na l lp a t i e n t sw i t hV E R A .
Bone edema is a pre-erosive lesion that represents true
inflammation and can be seen on MRI alone or sur-
rounding bone erosions [24]. Bone edema can be pre-
sent at any stage of RA and has been associated with
Figure 2 Fat-suppressed T1-weighted scans (A) coronal and (B) axial plane show an enhanced bone erosion (arrow). Rrepetition time/
500 msec, echo time/16 msec. Enhanced bone erosion (arrow) in the head of the second metacarpal.
Figure 3 Coronal T1-weighted fat-suppressed scan shows
enhancement of the inflammatory synovium in hand and wrist
joints. Repetition time (TR)/500 msec, echo time (TE)/16 msec.
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could decrease the aggressiveness of the disease process
m i g h tp r o b a b l ye x p l a i nt h ep r e s e n c eo fb o n ee d e m ai n
all patients with VERA.
In this study, the presence of synovitis was indepen-
dent of the disease duration, and the incidence was high
in all groups. In the VERA group, the incidence of syno-
vitis and bone erosions was almost similar. The exact
nature of the relation between synovitis and bone
damage remains unclear. The synovium seems to be the
prime target in the inflammatory course of RA. Cona-
ghan et al [12] showed that in ERA, synovitis appears to
be the primary abnormality, and bone damage occurs as
a late effect in proportion to the level of synovitis but
not in the absence of synovitis. Bone erosions are caused
by direct invasion of pannus into bone but also by pro-
osteoclastogenic imbalance, which is cytokine driven.
T h ep a t h o g e n i cm e c h a n i s mi nt h ev e r ye a r l yp e r i o do f
RA may be different from that in established disease.
Current theories of the immunopathogenesis of RA sug-
gest that abnormally sensitive to tumor necrosis factor
(TNF)-a bone marrow stem cells could travel via the
systematic circulation to the subchondral bone marrow,
where they initiate inflammatory and pre-erosive
changes or could travel to the synovial membrane,
where they promote synovial hyperplasia and inflamma-
tory synovitis. It seems that bone marrow edema repre-
sents a true inflammation in the bone and is a pre-
erosive lesion that can be reversible. Irreversibility of
bone edema with increasing disease chronicity is prob-
ably due to organization of the inflammation with for-
mation of dense vascularized infiltration and activation
of osteoclasts. Thus, in contrast to radiographic erosions
that reflect bone damage that has already occurred,
bone marrow edema represents early inflammatory infil-
trates in the subchondral bone [27-29].
In the current study, a significant difference in edema
and erosions was demonstrated between VERA and
ESTRA. This is in agreement with previous studies,
which, by using hand radiographs, showed that up to
60% of the patients develop joint erosions at the end of
Table 1 Clinical data in 57 patients with very early, early and established rheumatoid arthritis
VERA (n = 26) ERA (n = 18) ESTRA (n = 13)
Age, mean (SD), yr 56.15 (16.58) 61.86 (15.61) 60.40 (10.57)
Female/male 16/10 13/5 8/5
Disease duration, mean (SD), mo 1.65 (0.89) 7.83 (3.29) 33.30 (4.28)
Disease activity score for 28 joint indices, mean (SD) 5.55 (1.20) 5.25 (0.86) 5.50 (1.00)
C-reactive protein, mean (SD) 24.54 (10.50) 17.66 (11.62) 20.71 (10.80)
Rheumatoid factor positivity 19/26 12/18 9/13
Anticitrullinated cyclic peptide positivity 18/26 12/18 9/13
Demographic, clinical, and laboratory data in 57 patients with very early rheumatoid arthritis (VERA; disease duration, < 3 months), early rheumatoid arthritis
(ERA; disease duration, < 12 months), and established rheumatoid arthritis (ESTRA; disease duration, > 12 months)
Table 2 Prevalence of edema, erosions, and synovitis
(evaluated with the OMERACT RA MRI scoring system)
VERA (%) ERA (%) ESTRA (%)
Edema 100 93.33 100
Erosions 96.15 93.33 100
Synovitis 92.3 80 100
Prevalence of bone edema, erosions, and synovitis (evaluated with the
OMERACT RA MRI scoring system) in the three groups of patients with very
early rheumatoid arthritis (VERA; disease duration, < 3 months), early
rheumatoid arthritis (ERA; disease duration, < 12 months), and established
rheumatoid arthritis (ESTRA; disease duration, > 12 months)
Table 3 Analysis of variance with total score for bone
edema, erosions and synovitis
VERA ERA ESTRA FP value
Bone edema 15.5 (11.8) 16.5 (9.1) 24.4 (12.8) 2.31 < 0.05
Bone erosions 6.0 (5.2) 7.3 (5.09) 10.5 (7.02) 2.36 < 0.05
Synovitis 10.1 (5.2) 11.2 (4.5) 12.5 (3.3) NS
Values represent the mean (± SD). Analysis of variance between the three
groups, with total score for bone edema and erosions depicted with magnetic
resonance imaging of the hand in three groups of patients with very early
rheumatoid arthritis (VERA; disease duration, < 3 months), early rheumatoid
arthritis (ERA; disease duration, < 12 months), and established rheumatoid
arthritis (ESTRA; disease duration, > 12 months)
Analysis of variance demonstrated that the three groups were significantly
different. Least significant difference test revealed significant difference in
bone edema and erosions between VERA and ESTRA.
Table 4 Distribution of edema, erosions and synovitis in
hand and wrist joints
MCP CMC WRIST RADIOULNA
VERA ERA VERA ERA VERA ERA VERA ERA
Edema 5.0
(5.9)
4.0
(3.8)
2.7
(2.2)
2.7
(2.5)
7.1
(4.5)
8.3
(3.4)
0.6
(1.2)
1.3
(1.5)
Erosions 0.8
(1.3)
a
1.9
(1.7)
a
1.3
(1.6)
1.2
(1.7)
3.4
(3.0)
4.4
(4.2)
0.5
(0.8)
0.9
(1.6)
Synovitis 5.3
(3.4)
4.4
(3.5)
4.6
(2.6)
4.9
(3.4)
Distribution of bone edema, erosions, and synovitis in metacarpophalangeal
joints (MCP), base of metacarpal (CMC), wrist joints, and radioulnar joint area
in patients with very early rheumatoid arthritis (VERA; disease duration, < 3
months), and early rheumatoid arthritis (ERA; disease duration, < 12 months).
The distribution of erosions in separate joint areas in patients with VERA and
ERA revealed significant difference only in MCP joints (
aP < 0.05). No
difference was found in bone edema and synovitis.
Data are presented as mean (SD).
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did not reveal any relation between the MRI findings in
ERA and disease activity. A recent study performed in a
3-T MR unit by using a dynamic contrast-enhanced T1-
weighted sequence demonstrated a correlation between
synovitis and DAS-28. This study was performed in a
small series of patients, and only synovitis was evaluated
[31]. Further studies are needed in larger series of
patients to assess the usefulness of 3-T MRI in the
detection of hand-wrist lesions in patients with ERA.
Conclusions
In conclusion, bone edema, erosions and synovitis are
very early MRI findings of RA. MRI of the hand and
wrist on clinical diagnosis of RA is useful to assess the
degree of involvement.
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